Benchsci
Toronto, US · Founded 2015 · 211 employees on LinkedIn · 15 known investors
Find your way into Benchsci
Each arrow is one introduction. Sign up to fill in the first one.
Ask Tim McAdam to introduce you to Liran Belenzon
You →Tim · together at Benchsci →Liran
Ask Jamie Chen to introduce you to Tom Leung
You →Jamie · together at Benchsci →Tom
Sign up to find every way you can get introduced to Benchsci
- Your email: who you already know at Benchsci, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Benchsci team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams. Its tools help scientists select reagents and model systems and reason about targets, pathways, and mechanisms to reduce failed experiments.
Founders & leadership
Benchsci was founded in 2015 by David Qixiang Chen, PhD, Elvis Wianda, Liran Belenzon, Tom Leung, and David Chen.


Investors · 15
How we know: Inovia Capital's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · a partner's Signal profile · Not right? Tell us
How we know: open dataset · 500 Global portfolio 2026-08 · Not right? Tell us
How we know: Afore Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: BDC Growth Venture Fund's portfolio page · Not right? Tell us
How we know: F-Prime Capital's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: FounderFuel's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Golden Venture Partners's portfolio page · Not right? Tell us
How we know: Golden Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: Two Small Fish Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: University of Toronto Entrepreneurship Hatchery's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Benchsci do?
- BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams. Its tools help scientists select reagents and model systems and reason about targets, pathways, and mechanisms to reduce failed experiments.
- Who founded Benchsci?
- Benchsci was founded by David Qixiang Chen, PhD, Elvis Wianda, Liran Belenzon, Tom Leung, David Chen in 2015.
- Who are Benchsci's investors?
- Benchsci's investors include Inovia Capital, Generation Investment Management, Gradient Ventures, TCV, 500 Global, Afore Capital, BDC Growth Venture Fund, Creative Destruction Lab (CDL) and 7 more.
- Where is Benchsci headquartered?
- Benchsci is headquartered in Toronto, US.











